Bookmarks
Posted on by admin
Posted on by admin
Market Wire - Daxor Announces That Shertech Pharmacy Corp. Acquires BVA-100 Blood Volume Analyzer to Service Multiple Hospitals
February 1, 2012 --
Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial...
Business Wire - Quotient Receives FDA License to Sell a Full Range of Reagent Red Blood Cell Products in the USA
January 18, 2012 -- Quotient Biodiagnostics, is pleased to announce to blood banks that its range of ALBAcyteî Reagent Red Blood Cell products have been...
Market Wire - Daxor Announces That the Mayo Clinic in Scottsdale, Arizona Acquires BVA-100 Blood Volume Analyzer
January 12, 2012 --
Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial...
Journal of Drugs in Dermatology - The use of Etanercept Enbrel as sole treatment for grade I acute graft versus host disease
December 1, 2011 --
Sponsored by the University of Michigan Cancer Center. The purpose of this clinical trial is to see if treatment with etanercept for early...
Shape - Iron on tap
December 1, 2011 --
If you're one of the more than 6 million women of reproductive age who suffer from an iron deficiency, here's a potentially enjoyable way to...
Business Wire - New Data Confirm Hemolysis as Predictor of Thromboembolism and Early Death in Patients with PNH and Demonstrate Need To Test High-Risk Patients for PNH
December 1, 2011 -- Alexion Pharmaceuticals today announced the presentation of new data that underscore the severity of PNH, a debilitating, ultra-rare and...
Business Wire - ARRY-614 Demonstrates Positive Single Agent Activity in Patients with Myelodysplastic Syndromes
December 1, 2011 --
BOULDER, Colo. -- Array BioPharma Inc. (NASDAQ: ARRY) today announced positive dose-escalation/expansion data for its novel, small...
Market Wire - Daxor Announces the Veterans Affairs New York Harbor Healthcare System (VA NYHHS) Acquires BVA-100 Blood Volume Analyzer & Initiates Dialysis Study
December 1, 2011 --
Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced the start of a study utilizing the...
PR Newswire - Studies Assess Hydroxyurea Therapy and Pre-Operative Transfusions for Patients with Sickle Cell Disease
December 1, 2011 --
SAN DIEGO, Dec. 11, 2011 /PRNewswire-USNewswire/ -- Research assessing the safety and efficacy of hydroxyurea therapy in pediatric patients...
Market Wire - Daxor Announces That Harborview Medical Center of Seattle, WA Acquires BVA-100 Blood Volume Analyzer
November 22, 2011 --
Daxor Corporation (NYSE Amex: DXR), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial...